Local view for "http://purl.org/linkedpolitics/eu/plenary/2005-10-25-Speech-2-290"
| Predicate | Value (sorted: default) |
|---|---|
| rdf:type | |
| dcterms:Date | |
| dcterms:Is Part Of | |
| dcterms:Language | |
| lpv:document identification number |
"en.20051025.22.2-290"2
|
| lpv:hasSubsequent | |
| lpv:speaker | |
| lpv:spokenAs | |
| lpv:translated text |
"Mr President, ladies and gentlemen, I agree with Mrs Wallis that such a sensitive subject should probably have been examined more thoroughly. Nevertheless, we are also here this evening to give the Commissioner our views.
The directive under consideration still has many controversial areas subject to interpretation, which is why we would like clearer definition on certain essential points. We believe patents are important, but it must be made clear that legal and economic protection does not mean that everything is patentable.
It is important to understand that clear limits are also needed, especially in areas where the aim is to prevent infringements, as is happening with embryonic stem cells for the production of human parts and forms of cloning that are in fact banned under the directive.
The issue of patentability, which provides legal protection, Commissioner, therefore requires us to be careful not to permit any kind of concentration, which would arise if the scope of protection for DNA sequence patents were too broad and not restricted just to their specific uses.
To conclude, I hope we will have the opportunity to examine these topics in greater depth, in the knowledge that there are lines in this field that I believe must not be crossed, such as the boundaries of human dignity."@en1
|
Named graphs describing this resource:
The resource appears as object in 2 triples